Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
39.34
-0.83 (-2.07%)
At close: May 29, 2026, 4:00 PM EDT
39.92
+0.58 (1.47%)
After-hours: May 29, 2026, 7:47 PM EDT
Structure Therapeutics Employees
Structure Therapeutics had 220 employees as of December 31, 2025. The number of employees increased by 57 or 34.97% compared to the previous year.
Employees
220
Change (1Y)
57
Growth (1Y)
34.97%
Revenue / Employee
n/a
Profits / Employee
-$641,827
Market Cap
2.80B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 220 | 57 | 34.97% |
| Dec 31, 2024 | 163 | 70 | 75.27% |
| Dec 31, 2023 | 93 | 25 | 36.76% |
| Dec 31, 2022 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 601 |
| Arcutis Biotherapeutics | 354 |
| Vera Therapeutics | 339 |
| Dyne Therapeutics | 263 |
| Alumis | 227 |
| Relay Therapeutics | 193 |
| Disc Medicine | 154 |
| IDEAYA Biosciences | 145 |
GPCR News
- 3 days ago - Structure Therapeutics Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 22 days ago - Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 22 days ago - Structure Therapeutics Earnings release: Q1 2026 - Filings
- 22 days ago - Structure Therapeutics Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions - GlobeNewsWire
- 4 weeks ago - Canaccord starts Structure Therapeutics on oral weight loss pipeline - TheFly
- 4 weeks ago - Structure Therapeutics initiated with a Buy at Canaccord - TheFly
- 5 weeks ago - Structure Therapeutics Proxy statement: Proxy filing - Filings